Zhejiang Medicine Co., Ltd. (SHA:600216)
China · Delayed Price · Currency is CNY 14.72
+0.37 (2.58%)
Feb 3, 2026, 3:00 PM CST
Zhejiang Medicine Market Cap
Zhejiang Medicine has a market cap or net worth of 13.6 billion as of February 2, 2026. Its market cap has decreased by -8.50% in one year.
Market Cap
13.60B
Enterprise Value
11.52B
Revenue
8.96B
Ranking
n/a
PE Ratio
11.06
Stock Price
14.72
Market Cap Chart
Since January 2, 2001, Zhejiang Medicine's market cap has increased from 5.53B to 13.60B, an increase of 145.86%. That is a compound annual growth rate of 3.65%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 13.60B | 3.54% |
| Dec 31, 2025 | 13.14B | -13.86% |
| Dec 31, 2024 | 15.25B | 48.35% |
| Dec 29, 2023 | 10.28B | -8.23% |
| Dec 30, 2022 | 11.20B | -31.56% |
| Dec 31, 2021 | 16.37B | 25.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Guobang Pharma | 15.19B |
| ApicHope Pharmaceutical Group | 15.11B |
| Shanghai Shyndec Pharmaceutical | 14.00B |
| Guangdong Taienkang Pharmaceutical | 13.62B |
| Zhejiang Jingxin Pharmaceutical | 13.53B |
| Wedge Industrial | 13.44B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.36B |
| Porton Pharma Solutions | 13.20B |